Clearance evidence

Peptide

ATLPC0027686

Measured material

Specific molecular form

Endpoint

Clearance

ADMET domain

Excretion / Persistence

Value

Observation

An approximate 2-fold decrease in total serum clearance of lanreotide, with a consequent 2-fold increase in half-life and AUC was observed.

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

human · serum

Condition

Lanreotide · 6e4a41fd-a753-4362-87ee-8cc56ed3660d · 12.3 Pharmacokinetics · lanreotide renal impairment clearance auc change text · An approximate 2-fold decrease in total serum c...

Scientific source

DailyMed

Open source

Clearance evidence

Developability

Resources

Measurement